NLRP3 and type 2 diabetes mellitus: Indeed, emerging evidence demonstrates that NLRP3 inflammasome activation leads to hepatic metaflammation, contributing to abnormal lipid and glucose metabolism, exacerbating T2D and its complications [11,12].